Table 1.
Description of the sample—BCS versus healthy control (N = 892)
| Demographic | Total | BCS | Healthy control | p1 |
|---|---|---|---|---|
| N = 892 | N = 498 | N = 394 | ||
| Age at survey (self report; mean (SD)) | 45.9 (6.0) | 45.3 (4.8) | 46.5 (7.1) | 0.0025** |
| Years of education (mean (SD)) | 15.0 (2.6) | 14.8 (2.6) | 15.1 (2.5) | 0.1456 |
| Income (N (%)) | ||||
| <$30,000 | 85 (9.7) | 48 (9.8) | 37 (9.6) | 0.0913 |
| $30,000–75,000 | 335 (38.4) | 172 (35.2) | 163 (42.3) | |
| >$75,000 | 453 (51.9) | 268 (54.9) | 185 (48.1) | |
| Race (N (%)) | ||||
| Caucasian | 814 (91.3) | 454 (91.2) | 360 (91.4) | 0.4288 |
| African American | 44 (4.9) | 22 (4.4) | 22 (5.6) | |
| Other | 34 (3.8) | 22 (4.4) | 12 (3.0) | |
| Total number of comorbidities (mean (SD); median; range) | 1.3 (1.5); 1; 0–11 | 1.3 (1.5); 1; 0–11 | 1.4 (1.6); 1; 0–8 | 0.2572 |
| Stage of cancer (N (%)) | ||||
| Stage 1 | 114 (22.9) | na | na | |
| Stage 2 | 308 (61.9) | na | na | |
| Stage 3 | 66 (13.3) | na | na | |
| Type of surgery (N(%)) | ||||
| Mastectomy | 268 (53.8%) | na | na | |
| Lumpectomy | 230 (46.2%) | na | na | |
| Radiation therapy given (N (%)) | 319 (69.4) | na | na | |
| Current use of estrogen-blocking therapy (N (%)) | 195 (39.2) | na | na | |
| Years since diagnosis (mean (SD)) | 5.9 (1.5) | na | na | |
Notes: missing values were excluded for years of education (n = 12), income (n = 19), stage (n = 10), and radiation therapy (n = 38)
p1, p value for comparison across all the two groups (chi-square used for categorical variables, two-sided t-test used for continuous variables)
*p < .05, **p < .01, ***p < .001
Significant findings were highlighted in bold; p-values were inserted in the table notes and * inserted with significant values